Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Mar;9(1):e1-e81.
doi: 10.1016/j.kisu.2018.11.001. Epub 2019 Feb 20.

China Kidney Disease Network (CK-NET) 2015 Annual Data Report

Luxia Zhang  1   2   1   3   4   5   1   6   7   2   8 , Ming-Hui Zhao  1   3   4   5   1   6   7   2   8 , Li Zuo  4   5   1   6   7   2   8 , Yue Wang  5   1   6   7   2   8 , Feng Yu  1   6   7   2   8 , Hong Zhang  7   2   8 , Haibo Wang  2   8 ; CK-NET Work Group
Affiliations

China Kidney Disease Network (CK-NET) 2015 Annual Data Report

Luxia Zhang et al. Kidney Int Suppl (2011). 2019 Mar.

Erratum in

No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Geographical distribution of China Kidney Disease Network (CK-NET) collaborating renal centers in China. The size of each yellow circle and its corresponding number indicate the number of collaborating renal centers in the city or province.
Figure 2
Figure 2
Prevalence of CKD among different types of underlying disease. CKD, chronic kidney disease; CVD, cardiovascular disease; DM, diabetes mellitus; HT, hypertension.
Figure 3
Figure 3
Patients with CKD, stratified by sex and age group. CKD, chronic kidney disease.
Figure 4
Figure 4
Patients with CKD, stratified by urban versus rural area. CKD, chronic kidney disease.
Figure 5
Figure 5
Age distribution of CKD, stratified by sex. CKD, chronic kidney disease.
Figure 6
Figure 6
Sex distribution of CKD, stratified by age. CKD, chronic kidney disease.
Figure 7
Figure 7
Cause distribution of CKD. CKD, chronic kidney disease; CTIN, chronic tubulointerstitial nephritis; DKD, diabetic kidney disease; GN, CKD due to glomerulonephritis; HTN, hypertensive nephropathy; ON, obstructive nephropathy; Others, CKD due to other reasons.
Figure 8
Figure 8
Cause of CKD, stratified by urban versus rural area. CKD, chronic kidney disease; CTIN, chronic tubulointerstitial nephritis; DKD, diabetic kidney disease; GN, CKD due to glomerulonephritis; HTN, hypertensive nephropathy; ON, obstructive nephropathy; Others, CKD due to other reasons.
Figure 9
Figure 9
Cause of CKD, stratified by geographic region. C, Central China; CKD, chronic kidney disease; CTIN, chronic tubulointerstitial nephritis; DKD, diabetic kidney disease; E, East China; GN, CKD due to glomerulonephritis; HTN, hypertensive nephropathy; N, North China; NE, Northeast China; NW, Northwest China; ON, obstructive nephropathy; Others, CKD due to other reasons; S, South China; SW, Southwest China.
Figure 10
Figure 10
Staging of CKD. CKD, chronic kidney disease.
Figure 11
Figure 11
Prevalence of CVD, stratified by patient group. CHD, coronary heart disease; CKD, chronic kidney disease; CVD, cardiovascular disease; DM, diabetes mellitus.
Figure 12
Figure 12
Prevalence of CHD, stratified by sex. CHD, coronary heart disease; CKD, chronic kidney disease; DM, diabetes mellitus.
Figure 13
Figure 13
Prevalence of CHD, stratified by age. CHD, coronary heart disease; CKD, chronic kidney disease; DM, diabetes mellitus. Point size refers to the percentage of CHD.
Figure 14
Figure 14
Prevalence of stroke, stratified by sex. CKD, chronic kidney disease; DM, diabetes mellitus.
Figure 15
Figure 15
Prevalence of stroke, stratified by age. CKD, chronic kidney disease; DM, diabetes mellitus. Point size refers to the percentage of stroke.
Figure 16
Figure 16
Prevalence of heart failure, stratified by sex. CKD, chronic kidney disease; DM, diabetes mellitus.
Figure 17
Figure 17
Prevalence of heart failure, stratified by age. CKD, chronic kidney disease; DM, diabetes mellitus. Point size refers to the percentage of heart failure.
Figure 18
Figure 18
Prevalence of atrial fibrillation, stratified by sex. CKD, chronic kidney disease; DM, diabetes mellitus.
Figure 19
Figure 19
Prevalence of atrial fibrillation, stratified by age. CKD, chronic kidney disease; DM, diabetes mellitus. Point size refers to the percentage of atrial fibrillation.
Figure 20
Figure 20
Prevalence of CVD among patients with CKD. CHD, coronary heart disease; CKD, chronic kidney disease; CTIN, chronic tubulointerstitial nephritis; CVD, cardiovascular disease; DKD, diabetic kidney disease; GN, CKD due to glomerulonephritis; HTN, hypertensive nephropathy; ON, obstructive nephropathy; Others, CKD due to other reasons.
Figure 21
Figure 21
Prevalence of CHD among patients with CKD, stratified by cause and sex. CHD, coronary heart disease; CKD, chronic kidney disease; CTIN, chronic tubulointerstitial nephritis; DKD, diabetic kidney disease; GN, CKD due to glomerulonephritis; HTN, hypertensive nephropathy; ON, obstructive nephropathy; Others, CKD due to other reasons.
Figure 22
Figure 22
Prevalence of CHD among patients with CKD, stratified by cause and sex. CHD, coronary heart disease; CKD, chronic kidney disease; CTIN, chronic tubulointerstitial nephritis; DKD, diabetic kidney disease; GN, CKD due to glomerulonephritis; HTN, hypertensive nephropathy; ON, obstructive nephropathy; Others, CKD due to other reasons. Point size refers to the percentage of CHD.
Figure 23
Figure 23
Prevalence of stroke among patients with CKD, stratified by cause and sex. CKD, chronic kidney disease; CTIN, chronic tubulointerstitial nephritis; DKD, diabetic kidney disease; GN, CKD due to glomerulonephritis; HTN, hypertensive nephropathy; ON, obstructive nephropathy; Others, CKD due to other reasons.
Figure 24
Figure 24
Prevalence of stroke among patients with CKD, stratified by cause and age. CKD, chronic kidney disease; CTIN, chronic tubulointerstitial nephritis; DKD, diabetic kidney disease; GN, CKD due to glomerulonephritis; HTN, hypertensive nephropathy; ON, obstructive nephropathy; Others, CKD due to other reasons. Point size refers to the percentage of stroke.
Figure 25
Figure 25
Prevalence of heart failure among patients with CKD, stratified by cause and sex. CKD, chronic kidney disease; CTIN, chronic tubulointerstitial nephritis; DKD, diabetic kidney disease; GN, CKD due to glomerulonephritis; HTN, hypertensive nephropathy; ON, obstructive nephropathy; Others, CKD due to other reasons.
Figure 26
Figure 26
Prevalence of heart failure among patients with CKD, stratified by cause and age. CKD, chronic kidney disease; CTIN, chronic tubulointerstitial nephritis; DKD, diabetic kidney disease; GN, CKD due to glomerulonephritis; HTN, hypertensive nephropathy; ON, obstructive nephropathy; Others, CKD due to other reasons. Point size refers to the percentage of heart failure.
Figure 27
Figure 27
Prevalence of atrial fibrillation among patients with CKD, stratified by cause and sex. CKD, chronic kidney disease; CTIN, chronic tubulointerstitial nephritis; DKD, diabetic kidney disease; GN, CKD due to glomerulonephritis; HTN, hypertensive nephropathy; ON, obstructive nephropathy; Others, CKD due to other reasons.
Figure 28
Figure 28
Prevalence of atrial fibrillation among patients with CKD, stratified by cause and age. CKD, chronic kidney disease; CTIN, chronic tubulointerstitial nephritis; DKD, diabetic kidney disease; GN, CKD due to glomerulonephritis; HTN, hypertensive nephropathy; ON, obstructive nephropathy; Others, CKD due to other reasons. Point size refers to the percentage of atrial fibrillation.
Figure 29
Figure 29
Cardiovascular procedures stratified by patient group. CABG, coronary artery bypass grafting; CAG, coronarography; CKD, chronic kidney disease; DM, diabetes mellitus; PCI, percutaneous coronary intervention.
Figure 30
Figure 30
Cardiovascular procedures: CAG, stratified by sex. CAG, coronarography; CKD, chronic kidney disease; DM, diabetes mellitus.
Figure 31
Figure 31
Cardiovascular procedures: CAG, stratified by age. CAG, coronarography; CKD, chronic kidney disease; DM, diabetes mellitus. Point size refers to the percentage of CAG.
Figure 32
Figure 32
Cardiovascular procedures: PCI, stratified by sex. CKD, chronic kidney disease; DM, diabetes mellitus; PCI, percutaneous coronary intervention.
Figure 33
Figure 33
Cardiovascular procedures: PCI, stratified by age. CKD, chronic kidney disease; DM, diabetes mellitus; PCI, percutaneous coronary intervention. Point size refers to the percentage of PCI.
Figure 34
Figure 34
Cardiovascular procedures: CABG, stratified by sex. CABG, coronary artery bypass grafting; CKD, chronic kidney disease; DM, diabetes mellitus.
Figure 35
Figure 35
Cardiovascular procedures: CABG, stratified by age. CABG, coronary artery bypass grafting; CKD, chronic kidney disease; DM, diabetes mellitus. Point size refers to the percentage of CABG.
Figure 36
Figure 36
Cardiovascular procedures: pacemaker, stratified by sex. CKD, chronic kidney disease; DM, diabetes mellitus.
Figure 37
Figure 37
Cardiovascular procedures: pacemaker, stratified by age. CKD, chronic kidney disease; DM, diabetes mellitus. Point size refers to the percentage of pacemaker.
Figure 38
Figure 38
Cardiovascular procedures among patients with CKD. CABG, coronary artery bypass grafting; CAG, coronarography; CKD, chronic kidney disease; CTIN, chronic tubulointerstitial nephritis; DKD, diabetic kidney disease; GN, CKD due to glomerulonephritis; HTN, hypertensive nephropathy; ON, obstructive nephropathy; Others, CKD due to other reasons; PCI, percutaneous coronary intervention
Figure 39
Figure 39
Costs stratified by types of health insurance. Limited to 1.5 * third quartile. Red points refer to cost per person per year. CKD, chronic kidney disease; DM, diabetes mellitus; NRCMS, new rural co-operative medical care; UBMI, urban basic medical insurance.
Figure 40
Figure 40
Costs stratified by sex. Limited to 1.5 * third quartile. Red points refer to cost per person per year. CKD, chronic kidney disease; DM, diabetes mellitus.
Figure 41
Figure 41
Costs stratified by age group (mean). CKD, chronic kidney disease; DM, diabetes mellitus.
Figure 42
Figure 42
Length of stay stratified by types of health insurance. CKD, chronic kidney disease; DM, diabetes mellitus; NRCMS, new rural co-operative medical care; UBMI, urban basic medical insurance. Limited to 1.5 * third quartile. Red points refer to length of stay per person per year.
Figure 43
Figure 43
Length of stay stratified by sex. Limited to 1.5 * third quartile. Red points refer to length of stay per person per year. CKD, chronic kidney disease; DM, diabetes mellitus.
Figure 44
Figure 44
Length of stay stratified by age group (mean). CKD, chronic kidney disease; DM, diabetes mellitus.
Figure 45
Figure 45
In-hospital mortality rate stratified by different types of insurance. CKD, chronic kidney disease; DM, diabetes mellitus; NRCMS, new rural co-operative medical care; UBMI, urban basic medical insurance.
Figure 46
Figure 46
In-hospital mortality rate stratified by sex. CKD, chronic kidney disease; DM, diabetes mellitus.
Figure 47
Figure 47
In-hospital mortality rate stratified by age group. Point size refers to mortality rate. CKD, chronic kidney disease; DM diabetes mellitus.
Figure 48
Figure 48
Sex distribution of AKI, stratified by age. AKI, acute kidney injury.
Figure 49
Figure 49
Age distribution of AKI, stratified by sex. AKI, acute kidney injury.
Figure 50
Figure 50
Percentage of AKI with and without ICU stay, stratified by geographic regions. AKI, acute kidney injury; C, Central of China; E, East of China; ICU, intensive care unit; N, North of China; NE, Northeast of China; NW, Northwest of China; S, South of China; SW, Southwest of China.
Figure 51
Figure 51
Percentage of AKI among patients with CKD. AKI, acute kidney injury; CKD, chronic kidney disease; DKD, diabetic kidney disease; HTN, hypertensive nephropathy; GN, glomerulonephritis; CTIN, chronic tubulointerstitial nephropathy; ON, obstructive nephropathy; Others, CKD due to other reasons.
Figure 52
Figure 52
Percentage of CKD among patients with AKI, stratified by sex and age. AKI, acute kidney injury; CKD, chronic kidney disease.
Figure 53
Figure 53
Percentage of DM among patients with AKI, stratified by sex and age. AKI, acute kidney injury; DM, diabetes mellitus.
Figure 54
Figure 54
Distribution of HD and PD patients among different hospital grades. HD, hemodialysis; PD, peritoneal dialysis.
Figure 55
Figure 55
Incidence of dialysis patients, by age and sex.
Figure 56
Figure 56
All-cause mortality rate of dialysis patients, by age and sex.
Figure 57
Figure 57
Frequency of (a) hemoglobin and (b) serum ferritin measurement among dialysis patients, by modality. ESKD, end-stage kidney disease; HD, hemodialysis; PD, peritoneal dialysis.
Figure 58
Figure 58
Percentage of dialysis patients who underwent (a) calcium, (b) phosphorus, and (c) PTH testing per year. ESKD, end-stage kidney disease; HD, hemodialysis; PD, peritoneal dialysis; PTH, parathyroid hormone.
Figure 59
Figure 59
Percentage of dialysis patients received anemia related treatment. EPO, erythropoietin; ESKD, end-stage kidney disease; HD, hemodialysis; PD, peritoneal dialysis.
Figure 60
Figure 60
Percentage of dialysis patients who received MBD-related treatment. ESKD, end-stage kidney disease; HD, hemodialysis; MBD, mineral and bone disorder; PD, peritoneal dialysis.
Figure 61
Figure 61
Percentage of dialysis patients who underwent blood albumin testing. ESKD, end-stage kidney disease; HD, hemodialysis; PD, peritoneal dialysis.
Figure 62
Figure 62
Diabetes-related examinations among dialysis patients with diabetes mellitus. ESKD, end-stage kidney disease; HD, hemodialysis; PD, peritoneal dialysis.
Figure 63
Figure 63
Number of candidates.
Figure 64
Figure 64
Candidates, stratified by sex in 2015.
Figure 65
Figure 65
Candidates, stratified by age in 2015.
Figure 66
Figure 66
Geographic distribution of candidate location in 2015.
Figure 67
Figure 67
Candidates, stratified by causes in 2015.
Figure 68
Figure 68
Candidates, stratified by dialysis state in 2015.
Figure 69
Figure 69
Candidates, stratified by cause of removal in 2015.
Figure 70
Figure 70
Active candidates, stratified by waiting time in 2015.
See this image and copyright information in PMC

References

    1. Zhang L., Wang H., Long J. China Kidney Disease Network (CK-NET) 2014 Annual Data Report. Am J Kidney Dis. 2016;69(Suppl 2):S1–S149. - PMC - PubMed
    1. GBD 2013 Mortality and Causes of Death Collaborators Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;385:117–171. - PMC - PubMed
    1. Fried L.F., Emanuele N., Zhang J.H. Combined angiotensin inhibition for the treatment of diabetic nephropathy. N Engl J Med. 2013;369:1892–1903. - PubMed
    1. de Boer I.H., Rue T.C., Hall Y.N. Temporal trends in the prevalence of diabetic kidney disease in the United States. JAMA. 2011;305:2532–2539. - PMC - PubMed
    1. Saran R., Robinson B., Abbott K.C. US Renal Data System 2017 Annual Data Report: Epidemiology of Kidney Disease in the United States. Am J Kidney Dis. 2018;71:A7. - PMC - PubMed